Supporting oncology professionals through education

The content on this site is intended for healthcare professionals only

Video

ecancer's extensive video archive features interviews, panel discussions and conference coverage on almost every topic in oncology.
Latest
Popular

ABP 980, a biosimilar antibody for trastuzumab

Dr Richard Markus - Amgen, Conejo Valley, USA
ABP 980, a biosimilar antibody for trastuzumab ( Dr Richard Markus - Amgen, Conejo Valley, USA )
10 Sep 2017

New strategies in melanoma care

Dr Alexander van Akkooi - Netherlands Cancer Institute, Amsterdam, Netherlands
New strategies in melanoma care ( Dr Alexander van Akkooi - Netherlands Cancer Institute, Amsterdam, Netherlands )
10 Sep 2017

RANGE: docetaxel with or without ramucirumab for metastatic urothelial carcinoma

Prof Daniel Petrylak - Yale Cancer Center, New Haven, Connecticut, USA
RANGE: docetaxel with or without ramucirumab for metastatic urothelial carcinoma ( Prof Daniel Petrylak - Yale Cancer Center, New Haven, Connecticut, USA )
10 Sep 2017

STORM trial to identify genetic variability in metastatic breast cancer

Dr David Cox - Cancer Research Center of Lyon, Lyon, France
STORM trial to identify genetic variability in metastatic breast cancer ( Dr David Cox - Cancer Research Center of Lyon, Lyon, France )
9 Sep 2017

Reduced work ability in cancer survivors

Dr Cecilie Kiserud - Oslo University Hospital, Oslo, Norway
Reduced work ability in cancer survivors ( Dr Cecilie Kiserud - Oslo University Hospital, Oslo, Norway )
9 Sep 2017

Underprovision and inequality of specialised cancer care

Dr Emmanouil Saloustros - General Hospital of Heraklion 'Venizelio', Crete, Greece
Underprovision and inequality of specialised cancer care ( Dr Emmanouil Saloustros - General Hospital of Heraklion 'Venizelio', Crete, Greece )
9 Sep 2017

Regorafenib versus lomustine for relapsed glioblastoma

Dr Giuseppe Lombardi - Istituto Oncologico Veneto, Padova, Italy
Regorafenib versus lomustine for relapsed glioblastoma ( Dr Giuseppe Lombardi - Istituto Oncologico Veneto, Padova, Italy )
9 Sep 2017

Reviewing LORELEI, mindACT and ExteNET trials in breast cancer

Prof Miguel Martin - Hospital General Universitario Gregorio Marañón, Madrid, Spain
Reviewing LORELEI, mindACT and ExteNET trials in breast cancer ( Prof Miguel Martin - Hospital General Universitario Gregorio Marañón, Madrid, Spain )
9 Sep 2017

Osimertinib suitable for first line EGFRm lung cancer

Dr Suresh Ramalingam - Winship Cancer Institute, Atlanta, USA
Osimertinib suitable for first line EGFRm lung cancer ( Dr Suresh Ramalingam - Winship Cancer Institute, Atlanta, USA )
9 Sep 2017

Follow-up on the IFCT-0302 trial

Prof Virginie Westeel - University of Franche-Comté, Besançon, France
Follow-up on the IFCT-0302 trial ( Prof Virginie Westeel - University of Franche-Comté, Besançon, France )
9 Sep 2017

PACIFIC trial of durvalumab for lung cancer

Dr Luis Paz-Ares - Hospital Universitario Doce de Octubre, Madrid, Spain
PACIFIC trial of durvalumab for lung cancer ( Dr Luis Paz-Ares - Hospital Universitario Doce de Octubre, Madrid, Spain )
9 Sep 2017

Editor's Choice for August 2017

Prof Gordon McVie - Founding Editor, ecancer
Editor's Choice for August 2017 ( Prof Gordon McVie - Founding Editor, ecancer )
23 Aug 2017

More from ecancer

Register with ecancer to receive our newsletter

Register here

Explore patient resources at ecancerpatient

Visit site

Find out more about ecancer and the work we do

About ecancer

Support ecancer's work by making a donation